A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)

Abroad (travel likely)Recruiting

Conditions

Metastatic Colorectal Cancer · BRAF V600 Mutation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Zhiyu Chen, MD,PhD) · zychan75@163.com · 64175590

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer

Metastatic Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Nanjing, China · Nanjing, China

Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer

Metastatic Colorectal Cancer · BRAF V600E Mutation

Abroad (travel likely)Recruiting

Aarau, Switzerland · Baden, Switzerland

Early Detection of Advanced Adenomas and Colorectal Cancer

Colorectal Cancer · Colorectal Neoplasms · Colorectal Polyp

Abroad (travel likely)Recruiting

Monrovia, United States · San Diego, United States

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Non-Small Cell Lung Cancer · NSCLC · PDAC - Pancreatic Ductal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States · Sacramento, United States